MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today commemorated the fifth year of its annual community service program Hands On! Since the inception of the program in 2012, Sunovion employees have volunteered more than 20,000 hours to support youth organizations and community service efforts around the Company’s headquarters location in Marlborough, Massachusetts and its office in Fort Lee, New Jersey. During 2016, Sunovion will continue to expand Hands On! through employee volunteer efforts on projects throughout the U.S., as well as in communities where the Company has offices in the UK and Canada.
“Sunovion has a commitment to work with partners to support the local, regional and global community as part of our overall Corporate Social Responsibility efforts. This year, we are celebrating our ongoing collaboration with the United Way of Tri-County in Massachusetts and Volunteer Center of Bergen County in New Jersey to continue to help us with meaningful ways to build stronger communities where our employees live and work,” said Nobuhiko Tamura, Chairman and Chief Executive Officer, Sunovion.
Today, through the Hands On! program 321 Sunovion employees are supporting 19 projects including those in partnership with United Way of Tri-County and Volunteer Center of Bergen County to address various social, medical, educational and environmental needs.
“Sunovion received our 2016 Corporate Responsibility Award for its commitment to service and inspiring others to make a ripple effect in the community. United Way of Tri-County appreciates Sunovion’s long-standing partnership and volunteer efforts in local communities through its Hands On! program, as well as other contributions,” said Paul Mina, President and Chief Executive Officer, United Way of Tri-County. “With the dedication of Sunovion and its employees we are able to advance the common good and create community-wide change together.”
“Sunovion employees have a collective commitment to give back, make a difference together and improve lives. Our employees are passionate about making a positive impact, including through their volunteer work during our Hands On! program,” said Wendy Scoppa, Senior Manager, Community Relations, Sunovion.
About Sunovion Pharmaceuticals Inc.
Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Brovana® (arformoterol tartrate), Latuda® (lurasidone HCI), and most recently Aptiom® (eslicarbazepine acetate).
Headquartered in Marlborough, Mass., Sunovion is an indirect, wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc. Additional information can be found on the Company’s web sites: www.sunovion.com, www.sunovion.eu and www.sunovion.ca. Connect with Sunovion on Twitter @Sunovion and LinkedIn.
BROVANA is a registered trademark of Sunovion Pharmaceuticals Inc.
LATUDA is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd.
APTIOM is used under license from BIAL. © 2016 Sunovion Pharmaceuticals Inc.
© 2016 Sunovion Pharmaceuticals Inc.
For a copy of this release, visit Sunovion’s web site at www.sunovion.com